Entera Bio Ltd. (ENTX)
Develops oral pill versions of protein drugs to treat osteoporosis, obesity, and digestive disorders.
$3.21-0.18%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+64.5%
The outlook
Entera Bio is trading above both its 50- and 200-day moving averages, placing it in the upper portion of its 52-week range. Analyst price targets average roughly 181% above the current price of $3.21, though coverage may be limited. The overall data leans bullish, though today's movement was flat.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range70% of the way from its 52-week low to high
Price targetAvg target +181% vs current price
Market cap
$158.1M
52-wk high
$4.20
52-wk low
$0.91
50-day avg
$1.53
200-day avg
$1.69
Trailing P/E
—